BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24508781)

  • 1. Synthesis and characterization of Cu(II)-based anticancer chemotherapeutic agent targeting topoisomerase Iα: in vitro DNA binding, pBR322 cleavage, molecular docking studies and cytotoxicity against human cancer cell lines.
    Tabassum S; Zaki M; Afzal M; Arjmand F
    Eur J Med Chem; 2014 Mar; 74():509-23. PubMed ID: 24508781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New modulated design and synthesis of quercetin-Cu(II)/Zn(II)-Sn2(IV) scaffold as anticancer agents: in vitro DNA binding profile, DNA cleavage pathway and Topo-I activity.
    Tabassum S; Zaki M; Afzal M; Arjmand F
    Dalton Trans; 2013 Jul; 42(27):10029-41. PubMed ID: 23715526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New heterobimetallic Cu(II)-Sn2(IV) complex as potential topoisomerase I inhibitor: in vitro DNA binding, cleavage and cytotoxicity against human cancer cell lines.
    Tabassum S; Afzal M; Arjmand F
    J Photochem Photobiol B; 2012 Oct; 115():63-72. PubMed ID: 22884481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, crystal structure and antiproliferative activity of Cu(II) nalidixic acid-DACH conjugate: comparative in vitro DNA/RNA binding profile, cleavage activity and molecular docking studies.
    Arjmand F; Yousuf I; Hadda Tb; Toupet L
    Eur J Med Chem; 2014 Jun; 81():76-88. PubMed ID: 24826817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and characterization of new transition metal {Cu(II), Ni(II) and Co(II)} L-phenylalanine-DACH conjugate complexes: in vitro DNA binding, cleavage and molecular docking studies.
    Shamsi M; Yadav S; Arjmand F
    J Photochem Photobiol B; 2014 Jul; 136():1-11. PubMed ID: 24815057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbohydrate linked organotin(IV) complexes as human topoisomerase Iα inhibitor and their antiproliferative effects against the human carcinoma cell line.
    Khan RA; Yadav S; Hussain Z; Arjmand F; Tabassum S
    Dalton Trans; 2014 Feb; 43(6):2534-48. PubMed ID: 24310209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and crystal structure determination of copper(II)-complex: In vitro DNA and HSA binding, pBR322 plasmid cleavage, cell imaging and cytotoxic studies.
    Tabassum S; Zaki M; Ahmad M; Afzal M; Srivastav S; Srikrishna S; Arjmand F
    Eur J Med Chem; 2014 Aug; 83():141-54. PubMed ID: 24953031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure elucidation of a cobalt(II) complex as topoisomerase I inhibitor: in vitro DNA binding, nuclease and RBC hemolysis.
    Ahmad M; Afzal M; Tabassum S; Kalińska B; Mrozinski J; Bharadwaj PK
    Eur J Med Chem; 2014 Mar; 74():683-93. PubMed ID: 24287075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New modulated design, docking and synthesis of carbohydrate-conjugate heterobimetallic CuII-SnIV complex as potential topoisomerase II inhibitor: in vitro DNA binding, cleavage and cytotoxicity against human cancer cell lines.
    Tabassum S; Afzal M; Arjmand F
    Eur J Med Chem; 2014 Mar; 74():694-702. PubMed ID: 24268597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic insights into a novel chromone-appended Cu(II) anticancer drug entity: in vitro binding profile with DNA/RNA substrates and cytotoxic activity against MCF-7 and HepG2 cancer cells.
    Yousuf I; Arjmand F; Tabassum S; Toupet L; Khan RA; Siddiqui MA
    Dalton Trans; 2015 Jun; 44(22):10330-42. PubMed ID: 25970097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular drug design, synthesis and structure elucidation of a new specific target peptide based metallo drug for cancer chemotherapy as topoisomerase I inhibitor.
    Tabassum S; Al-Asbahy WM; Afzal M; Arjmand F; Bagchi V
    Dalton Trans; 2012 Apr; 41(16):4955-64. PubMed ID: 22407358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular drug design, synthesis and crystal structure determination of CuII-SnIV heterobimetallic core: DNA binding and cleavage studies.
    Arjmand F; Parveen S; Afzal M; Toupet L; Ben Hadda T
    Eur J Med Chem; 2012 Mar; 49():141-50. PubMed ID: 22305542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chiral heterobimetallic complexes targeting human DNA-topoisomerase Iα.
    Tabassum S; Asim A; Khan RA; Hussain Z; Srivastav S; Srikrishna S; Arjmand F
    Dalton Trans; 2013 Dec; 42(48):16749-61. PubMed ID: 24077532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Water-soluble DNA minor groove binders as potential chemotherapeutic agents: synthesis, characterization, DNA binding and cleavage, antioxidation, cytotoxicity and HSA interactions.
    Fu XB; Liu DD; Lin Y; Hu W; Mao ZW; Le XY
    Dalton Trans; 2014 Jun; 43(23):8721-37. PubMed ID: 24770345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and characterization of copper(II) and zinc(II)-based potential chemotherapeutic compounds: their biological evaluation viz. DNA binding profile, cleavage and antimicrobial activity.
    Tabassum S; Asim A; Arjmand F; Afzal M; Bagchi V
    Eur J Med Chem; 2012 Dec; 58():308-16. PubMed ID: 23137447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of heterobimetallic topoisomerase I and II inhibitor complexes: in vitro DNA binding, interaction with 5'-GMP and 5'-TMP and cleavage studies.
    Arjmand F; Muddassir M
    J Photochem Photobiol B; 2010 Oct; 101(1):37-46. PubMed ID: 20638859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enantiomeric specificity of biologically significant Cu(II) and Zn(II) chromone complexes towards DNA.
    Arjmand F; Jamsheera A; Afzal M; Tabassum S
    Chirality; 2012 Dec; 24(12):977-86. PubMed ID: 23001645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and docking studies of novel benzopyran-2-ones with anticancer activity.
    Ismail MM; Rateb HS; Hussein MM
    Eur J Med Chem; 2010 Sep; 45(9):3950-9. PubMed ID: 20580139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chiral preference of L-tryptophan derived metal-based antitumor agent of late 3d-metal ions (Co(II), Cu(II) and Zn(II)) in comparison to D- and DL-tryptophan analogues: their in vitro reactivity towards CT DNA, 5'-GMP and 5'-TMP.
    Arjmand F; Muddassir M; Khan RH
    Eur J Med Chem; 2010 Sep; 45(9):3549-57. PubMed ID: 20537435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure elucidation of a copper(II) Schiff-base complex: in vitro DNA binding, pBR322 plasmid cleavage and HSA binding studies.
    Tabassum S; Ahmad M; Afzal M; Zaki M; Bharadwaj PK
    J Photochem Photobiol B; 2014 Nov; 140():321-31. PubMed ID: 25222146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.